Etiology and Treatment Approaches for Trichomoniasis
The disease is caused by the microorganism Trichomonas vaginalis. The main goal of pharmacotherapy is the complete eradication of the pathogen from the patient's body.
To combat the infection, the baseline drug class of nitroimidazoles is used, which includes well-known medications such as:
- Metronidazole
- Ornidazole
- Tinidazole
Dosage forms of these medications allow for both systemic use as tablets and local use via vaginal suppositories. Nitrofurans, particularly furazolidone, may be prescribed as an alternative therapy.
Features of Giardiasis Therapy
The pathogenesis of giardiasis is associated with the localization of parasites in the proximal intestine, as well as in the bile ducts and the gallbladder itself. The reproduction of pathogens in these areas often leads to the clinical consequence of cholecystitis development.
The arsenal of antiprotozoal agents for this pathology includes:
- Nitroimidazoles (metronidazole, tinidazole).
- Specific agents — aminoquinol and emetine hydrochloride.
The choice of a specific drug depends on the clinical presentation and the course of the pathological process.
Classification of Main Medications
Pharmacological agents used for these protozoal infections are divided into several categories. Within the classification of the main class of antiprotozoal drugs, nitroimidazoles are highlighted and contrasted with other pharmacological classes (such as macrolides, tetracyclines, and fluoroquinolones). In clinical practice, nitroimidazoles form the basis of therapeutic regimens for both trichomoniasis and giardiasis.